Log In
Register
Facebook icon
LinkedIn icon
Instagram icon
Cosmetic Ingredients
Formulas/Products
Research
Regulations
Testing
News
Leaders
Multimedia
Calendar
Home
Search
Search Cosmetics & Toiletries: Page 2
Article
Company
Document
Event
News
Podcast
Video
Webcast
Cosmetic Ingredients
Formulas/Products
Anti-aging/Face
AP/Deodorant
Bath/Shower
Color Cosmetics
Formulating Basics
Hair Care
Nutricosmetics
Oral Care
Skin Care
Sun Care
Tech/Equipment/Production
Multimedia
News
Regulations
Research
Testing
Enter search phrase
Search
292 Results
Section: Formulas/Products
Safety/Stability
Sunscreen Absorption Makes Waves Again, FDA Shifts Toward Test Sample Selection
Questions of sunscreen absorption made waves once again in a recent report in the
Wall Street Journal
. Prior reports found no cause for concern while more recently, the FDA turned its focus to the selection method for sunscreens used in absorption tests.
Regional
FDA Pushes Higher Limits, New Labeling and More Data for Sunscreens
Broad spectrum sunscreens are critical for preventing skin cancer and UV damage, yet many of their essential requirements have not been updated in years. This was the driver for new sunscreen regulatory rules proposed by the FDA.
SPF/Sun
FDA Publishes Opinion on Two Sunscreen TEAs and Is Urged for More Action by PASS
The end of February was busy for the U.S. Food and Drug Administration (FDA), which published two letters on the Time and Extent Applications (TEAs) for diethylhexyl butamido triazone (Uvasorb HEB) and amiloxate (Neo Heliopan E 1000), finding insufficient scientific evidence to claim either as generally recognized as safe and effective (GRASE) and denying their addition to the OTC Sunscreen Monograph.
Regional
Sunscreen Innovation Act Passes: What Does it Mean?
The Public Access to SunScreens (PASS) Coalition applauded the U.S. Senate's passage of the Sunscreen Innovation Act (S. 2141). While the Act aims to streamline the approval process for new sunscreen actives, will it? Industry expert David Steinberg gives his take.
Claims/Labeling
FDA Weighs in on Holographic Cosmetics
Holographic, iridescent and other special effect color additives have been allowed to shine in recent consumer trends. Click through for the U.S. Food and Drug Administration's take on how these additives are regulated.
Claims/Labeling
FDA Issues New Guidances on Nanotechnology
The US Food and Drug Administration has issued two new draft guidances on the use of nanotechnology by the cosmetics and foods industries.
Actives
U.S. FDA Hand Sanitizer Solutions Explained
The U.S. Food and Drug Administration has liberalized the compounding of alcohol-based hand sanitizers such that any registered compounder can create these products as long as they follow the published formulas and guidelines. This article clears up the math on what these guidelines allow.
Claims/Labeling
FDA Hones in on Cosmetic Claims
The FDA issued five such letters since November 2014, the most recent being sent to StriVectin. Following those letters, the FDA has also issued a document that clarifies cosmetic versus drug claims for the consumer to highlight what cosmetic companies are able to say.
Regional
FDA Updates CFSAN Education Resource Library
Designed for personal and professional use, the library covers cosmetic safety, dietary supplements, food safety, nutrition and industry information such as food defense.
Regional
US FDA Releases Report on Color Additives
The U.S. Food and Drug Administration has released is first quarter report for 2019 on certified color additives.
Colorant
New Black Pigment Approved By FDA
D&C Black No. 3, or "bone black," has been approved by the US Food and Drug Administration (FDA) for formulation into eye shadow, eyeliner, mascara and face powder.
Claims/Labeling
FDA Issues Final Guidance on Nanomaterials
On June 26, 2014, The U.S. Food and Drug Administration (FDA) issued Final Guidance for Industry: Safety of Nanomaterials in Cosmetics, a final guidance document addressing the use of nanotechnology in cosmetics.
Claims/Labeling
FDA Cracks Down on Skin Lighteners
Skin whitening products walk the line between cosmetics and drugs, and often carry dangerous side effects. Flawless Beauty's injectable whitening products were struck down by a federal judge, putting lightening products under the lens.
Organic/COSMOS
Will CBD Cosmetics Face Greater FDA Scrutiny?
As the demand for CBD products continue to grow in 2020, so will the U.S. Food and Drug Administration (FDA) crackdown on their regulation. As explained in this report, the FDA plans to continue investing in regulations for a wider spectrum of CBD-containing cosmetics and foods.
Claims/Labeling
FDA Discusses 'Natural' in Food, Beverage Labeling
The U.S. Food and Drug Administration is finally talking about it: the word
natural
. Will this discussion move to cosmetics, next?
Tech Transfer
Prescription Polymer Nail Treatment Approved by the FDA
The U.S. Food and Drug Administration (FDA) has approved a prescription polymer treatment for brittle nail symdrome (nail dystrophy).
Regional
VIDEO: 2 Questions on the FDA's Triclosan Ruling
The FDA's ruling on triclosan raises two questions, which David C. Steinberg describe in this fourth video in our series. However, he concedes that fighting the ruling is like "doubling down on an already-lost bet."
Hair Care
FDA Approves First Systemic Alopecia Areata Treatment
Olumiant is a Janus kinase (JAK) inhibitor, which blocks the activity of one or more of a specific family of enzymes, interfering with the pathway that leads to inflammation to thereby treat patients with alopecia areata.
Previous Page
Page 2 of 17
Next Page